Latest News in the pharma Industry

Research & Development

GSK presents new data for shingles candidate vaccine

GSK presents new data for shingles candidate vaccine

27 Oct 2016

New studies support flexible dosing and co-administration with flu vaccine.

Read more 
Allergan to acquire GI disease subsidiary of Rhythm Holding Company

Allergan to acquire GI disease subsidiary of Rhythm Holding Company

27 Oct 2016

Acquisition expands Allergan's gastroenterology pipeline.

Read more 
Sanofi Pasteur, Fiocruz, and WRAIR to collaborate on Zika vaccine research

Sanofi Pasteur, Fiocruz, and WRAIR to collaborate on Zika vaccine research

27 Oct 2016

The three research organizations have a history of flavivirus vaccine collaboration.

Read more 
Skin patch to treat peanut allergy shows benefit in children

Skin patch to treat peanut allergy shows benefit in children

26 Oct 2016

NIH-funded study suggests patch is safe, convenient mode of treatment.

Read more 
Boehringer Ingelheim's adalimumab biosimilar candidate shows promise

Boehringer Ingelheim's adalimumab biosimilar candidate shows promise

26 Oct 2016

Phase III study established equivalence in efficacy and similar safety profile between BI 695501 and Humira (adalimumab) in patients with active rheumatoid arthritis.

Read more 
Teva and IBM expand global partnership to enable drug development and chronic disease management with Watson

Teva and IBM expand global partnership to enable drug development and chronic disease management with Watson

26 Oct 2016

Programs include a systematic approach to drug repurposing and data-driven, proactive chronic disease management - both fueled by the IBM Watson Health Cloud.

Read more 
New results presented for Opdivo (nivolumab)

New results presented for Opdivo (nivolumab)

25 Oct 2016

Results demonstrate encouraging response rate in an expanded population of heavily pre-treated classical Hodgkin lymphoma patients.

Read more 
Fighting cancer with the power of immunity

Fighting cancer with the power of immunity

24 Oct 2016

New treatment elicits two-pronged immune response that destroys tumors in mice.

Read more 
FDA approves sNDA for Xtandi capsules in advanced prostate cancer

FDA approves sNDA for Xtandi capsules in advanced prostate cancer

23 Oct 2016

Data demonstrate improvement in radiographic progression-free survival in patients with metastatic castration-resistant prostate cancer who were treated with enzalutamide compared to patients who were treated with bicalutamide.

Read more 
Merck trial studying Keytruda in advanced bladder cancer meets primary endpoint and stops early

Merck trial studying Keytruda in advanced bladder cancer meets primary endpoint and stops early

23 Oct 2016

Keytruda is the first immunotherapy to show improved overall survival compared with chemotherapy in urothelial cancer.

Read more 
Positive results from two pivotal Phase 3 studies of Revefenacin for the treatment of COPD

Positive results from two pivotal Phase 3 studies of Revefenacin for the treatment of COPD

20 Oct 2016

Top-line results across more than 1,250 moderate to very severe COPD patients confirmed that both Phase III studies met their primary efficacy endpoint.

Read more 
SOTIO and NBE Therapeutics sign collaboration and license agreement for next-generation ADCs

SOTIO and NBE Therapeutics sign collaboration and license agreement for next-generation ADCs

20 Oct 2016

Collaboration will focus on the discovery, non-clinical development and manufacturing of novel ADC products against undisclosed targets.

Read more